Fenton J W, Ofosu F A, Brezniak D V, Hassouna H I
New York State Department of Health, Wadsworth Center for Laboratories and Research, Albany.
Hematol Oncol Clin North Am. 1993 Dec;7(6):1107-19.
Unlike other factors in blood coagulation and fibrinolysis, thrombin has several functions in hemostasis from injury to recovery. Because of continual consumption, thrombin generation controls prethrombotic thrombin functions and may be prevented by inactivation of its precursors or by inhibition of thrombin-mediated amplification steps. The direct activation product of prothrombin, alpha-thrombin, not only converts fibrinogen into clottable fibrin but also is actively incorporated into the forming thrombus, where it is protected and transformed into other or inactive forms with thrombus maturation. Larger protein inhibitors, such as antithrombin III, cannot penetrate the thrombus, whereas hirudin and small thrombin inhibitors can. Unique structural features of thrombin allow the design and synthesis of a variety of small inhibitors. Such small inhibitors may prevent rethrombosis upon lysis of immature thrombi. On the other hand, such intervention must be used with caution, because low levels of thrombin appear to promote wound healing. In this regard, the scars of healing are but manifestations of the many functions of thrombin.
与血液凝固和纤维蛋白溶解中的其他因素不同,凝血酶在从损伤到恢复的止血过程中具有多种功能。由于持续消耗,凝血酶生成控制血栓形成前的凝血酶功能,并且可以通过其前体的失活或凝血酶介导的放大步骤的抑制来预防。凝血酶原的直接激活产物α-凝血酶不仅将纤维蛋白原转化为可凝结的纤维蛋白,而且还被积极地整合到正在形成的血栓中,在那里它受到保护并随着血栓成熟而转化为其他形式或无活性形式。较大的蛋白质抑制剂,如抗凝血酶III,无法穿透血栓,而水蛭素和小的凝血酶抑制剂则可以。凝血酶独特的结构特征允许设计和合成各种小抑制剂。这种小抑制剂可能会在未成熟血栓溶解时防止再次形成血栓。另一方面,这种干预必须谨慎使用,因为低水平的凝血酶似乎促进伤口愈合。在这方面,愈合的疤痕不过是凝血酶多种功能的表现。